Living definition
What is Moderna mRNA-1469 (Bundibugyo Ebola Vaccine, Phase 1)?
Vaccines & Immunotherapy Bio, Health & Neuro
- As of
- 2026-08-20
- Revision
- 2026-08-17.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
Moderna mRNA-1469 (Bundibugyo Ebola Vaccine, Phase 1) is an investigational messenger-RNA vaccine aimed at the Bundibugyo species of ebolavirus, a strain outside the coverage of the licensed ebolavirus vaccines. It instructs the recipient's cells to make a viral protein so the immune system learns to recognise that strain.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-08-20, verified readiness is 13 (claimed 15, reported 15, gap 2) — Strong evidence strength; current signals suggest Track; not yet.
The readiness fact belongs to the canonical Readiness Verdict for Moderna mRNA-1469 (Bundibugyo Ebola Vaccine, Phase 1).
Dataset approval
Human editorial release
pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)
- Dataset
- 2026-08-17.1
- Hash
- sha256:0c37108a182f510fc8cf4d1dfc3a30339f2b59e62654201edea2f530a268707e
- Approved
- 2026-08-17